These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15131522)

  • 41. Impractical features of long-acting risperidone.
    Amdur MA
    Psychiatr Serv; 2004 Dec; 55(12):1443; author reply 1443-4. PubMed ID: 15572577
    [No Abstract]   [Full Text] [Related]  

  • 42. Novel uses for risperidone: focus on depressive, anxiety and behavioral disorders.
    Ravindran AV; Bradbury C; McKay M; da Silva TL
    Expert Opin Pharmacother; 2007 Aug; 8(11):1693-710. PubMed ID: 17685886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risperidone for dementia-related disturbed behavior in nursing home residents: a clinical experience.
    Goldberg RJ; Goldberg J
    Int Psychogeriatr; 1997 Mar; 9(1):65-8. PubMed ID: 9195280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychosis with Huntington's disease: role of antipsychotic medications.
    Ding J; Gadit AM
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25139915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risperidone in the elderly: a pharmacoepidemiologic study.
    Zarate CA; Baldessarini RJ; Siegel AJ; Nakamura A; McDonald J; Muir-Hutchinson LA; Cherkerzian T; Tohen M
    J Clin Psychiatry; 1997 Jul; 58(7):311-7. PubMed ID: 9269252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosis and treatment of psychotic symptoms in elderly patients.
    Lake JT; Rahman AH; Grossberg GT
    Drugs Aging; 1997 Sep; 11(3):170-7. PubMed ID: 9303277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risperidone in the treatment of acute confusional state (delirium) due to neuropsychiatric lupus erythematosus: case report.
    Nishimura K; Omori M; Horikawa N; Tanaka E; Furuya T; Harigai M
    Int J Psychiatry Med; 2003; 33(3):299-303. PubMed ID: 15089010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risperidone for control of agitation in dementia patients.
    Falsetti AE
    Am J Health Syst Pharm; 2000 May; 57(9):862-70. PubMed ID: 10840527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebrovascular events after treatment of dementia patients with risperidone.
    Wancata J
    Int Psychogeriatr; 2004 Dec; 16(4):493-5. PubMed ID: 15715366
    [No Abstract]   [Full Text] [Related]  

  • 50. Antipsychotic drug use in neurodegenerative disease in the elderly: problems and potential from a pharmacological perspective.
    Reynolds GP
    Expert Opin Pharmacother; 2001 Apr; 2(4):543-8. PubMed ID: 11336605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychiatric Disorders--SMi conference. 24-25 May 2004, London, UK.
    Kibble A
    IDrugs; 2004 Jul; 7(7):648-52. PubMed ID: 15243866
    [No Abstract]   [Full Text] [Related]  

  • 52. [Atypical antipsychotics for elderly patients: to prescribe or to ban?].
    Rollini M; Schulz P
    Rev Med Suisse; 2008 Apr; 4(153):979-80, 982-4. PubMed ID: 18549086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychiatric and neuropsychological abnormalities in Huntington's disease: a case study.
    Madhusoodanan S; Brenner R; Moise D; Sindagi J; Brafman I
    Ann Clin Psychiatry; 1998 Sep; 10(3):117-20. PubMed ID: 9781475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risperidone in chorea and psychosis of Huntington's disease.
    Erdemoglu AK; Boratav C
    Eur J Neurol; 2002 Mar; 9(2):182-3. PubMed ID: 11882064
    [No Abstract]   [Full Text] [Related]  

  • 55. Risperidone for resistant anxiety in elderly persons.
    Moríñigo A; Blanco M; Labrador J; Martín J; Noval D
    Am J Geriatr Psychiatry; 2005 Jan; 13(1):81-82. PubMed ID: 15653944
    [No Abstract]   [Full Text] [Related]  

  • 56. Successfully treated delirium in an extremely elderly patient by switching from risperidone to ramelteon.
    Tsuda A; Nishimura K; Naganawa E; Otsubo T; Ishigooka J
    Psychiatry Clin Neurosci; 2013 Feb; 67(2):130. PubMed ID: 23438172
    [No Abstract]   [Full Text] [Related]  

  • 57. The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use.
    Yunusa I; El Helou ML
    Front Pharmacol; 2020; 11():596. PubMed ID: 32528275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risperdal advertising in JAGS. Journal of the American Geriatrics Society.
    Beers MH
    J Am Geriatr Soc; 1999 Mar; 47(3):377. PubMed ID: 10078907
    [No Abstract]   [Full Text] [Related]  

  • 59. Response to "Risperidone and sulpiride: Brands vs generics".
    Hsu CW; Lee SY; Wang LJ
    Schizophr Res; 2018 May; 195():274. PubMed ID: 28844637
    [No Abstract]   [Full Text] [Related]  

  • 60. Real-World Outcomes of Once-Daily Risperidone Dosing.
    Gupta S; Al-Samarrai S; Masand PS; Lentz BJ; Keller PJ; Droney TM
    Prim Care Companion J Clin Psychiatry; 2000 Apr; 2(2):55-57. PubMed ID: 15014584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.